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The Human Genetic Resources play an important role in the biomedical research. 
Due to the life patent, the biotechnological products developed from the human 
tissues may bring great economic interests, thereby causing a dilemma that the 
patentee and biotechnology company share the high profits while the human genetic 
resources providers are excluded from the circle of interests. This thesis discusses the 
tough issue and designs the innovative means to resolve it. 
Except for the preface and conclusion, this article consists of four chapters. 
Chapter introduces two typical cases of access to human genetic resources and Ⅰ
benefit sharing in the U.S., and presents the problems encountered in China. 
Chapter Ⅱ analyzes the legal nature of human genetic resources. First, this 
article points out the distinction in the legal basis between human genetic resources 
and animal & plant genetic resources. Second, this paper discusses that the tissues 
separated from the body have the characteristics of thing and the ownership of the 
removed tissues belongs to the originator. Finally, this thesis states that human genetic 
resources provider is neither the patentee nor the joint inventor pursuant to the patent 
law. Therefore, human genetic resources providers do not share the patent rights but 
share the interests brought by the biotechnology products. 
Chapter Ⅲ discusses the mechanism for access to human genetic resources. First, 
this article examines informed consent doctrine both in the physician-patient context 
and in the researcher-tissue source context, thereby requiring researchers or 
physicians to disclose the potential commercial interests in the human tissues. Then, 
this paper proposes that genetic privacy of research participant shall be protected due 
to the fact that genetic information is paramount to one’s life. 
Chapter Ⅳ discusses the mechanism for benefit sharing. First, this article states 
that the justification of benefit sharing is participant’s property rights in human tissues. 
Second, the scope of benefit sharing, clarified in this thesis, includes not only the 
profits of the products but also the diagnostic and therapeutic tools developed from 
the human resources. Third, after analyzing two models raised by the U.S. scholars, 
this article proposes the alternative model that would protect the interests of the 














industry. That is to accord the participant property rights in his tissue, disregard the 
free market model for access to human genetic resources and calculate the monetary 
compensation based on the market value of biotechnology products. 
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前  言 1
 














重大进展，及我国 1998 年克隆的高频耳聋疾病基因、2001 年发现的遗传性乳光
牙本质致病基因和短指基因都是利用了疾病家系或特殊人群遗传资源。因此许多
国家已经投入大量的资金、人力和物力开展遗传资源的收集，并且注意收集其他








                                                 
① 人类基因组计划起始于 1990 年, 原计划用 15 年的时间完成人类基因组的测序和图谱分析。但由于技术
的飞速发展, 完成这一宏伟目标的时间提前到了 2003 年。“What is the Human Genome Project?”[EB/OL]  
http://www.ornl.gov/sci/techresources/Human_Genome/project/about.shtml, 2005-12-07. 
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